| GUSTO | Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries ... |
|---|---|
| HTC | hepatoma cell; hepatoma tissue culture; homozygous typing cell |
| ICT | icteric, icterus; indirect Coombs test; inflammation of connective tissue; insulin coma therapy; int... |
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
| IVOTTS | Irvine viable organ-tissue transport system |
| keratinocyte growth factor | <growth factor> A growth factor structurally related to fibroblast growth factor. (18 Nov 1997) |
|---|---|
| urban growth boundary | A land use boundary surrounding a city. Urban land uses are permitted within the urban growth boundary. (05 Dec 1998) |
| fibroblast growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| fibroblast growth factor, acidic | <chemical> A growth factor which has been isolated from a variety of cells. It contains 154 amino acid residues and has potent heparin-binding activity. Heparin potentiates the biological activities of afgf. The growth factor is an extremely potent inducer of DNA synthesis in a variety of normal diploid mammalian cell types from mesoderm and neuroectoderm lineages and also has chemotactic and mitogenic activities. Chemical name: Fibroblast growth factor (human brain acidic protein moiety reduced) (12 Dec 1998) |
| fibroblast growth factor, basic | A single-chain polypeptide of approximately 15-16 kD which has been isolated from a variety of cells. It has a 55% amino acid residue identity to acidic fibroblast growth factor and has potent heparin-binding activity. However, in contrast to the acidic fibroblast growth factor, heparin does not potentiate the biological activities of bfgf. The growth factor is an extremely potent inducer of DNA synthesis in a variety of normal diploid mammalian cell types from mesoderm and neuroectoderm lineages and promotes cellular differentiation in vitro. (12 Dec 1998) |
| fibroblast growth factor receptor | Family of receptor tyrosine kinases for fibroblast growth factor. (18 Nov 1997) |
| fibroblast growth factor receptor-like embryonic kinase | <enzyme> Found in avian embryonic tissue; involved in early differentiation of skeletal muscle. Registry number: EC 2.7.1.- Synonym: frek (26 Jun 1999) |
| foetal growth retardation | The failure of a foetus to maintain its expected growth potential at any gestational stage. (12 Dec 1998) |
| adenoid tissue | A structure found within the lymphatic system that consists of lymphocytes within a network of fibres. (09 Oct 1997) |
| adipose tissue | <anatomy> Connective tissue that has been specialised to store fat. See: adipocyte. (25 Jun 1999) |
| aerenchymous tissue | A type of plant tissue in which cells are unusually large, resulting in large air spaces in the plant organ, such tissues are often referred to as spongy and usually provide increased buoyancy. (09 Oct 1997) |
| areolar tissue | Loose, irregularly arranged connective tissue that consists of collagenous and elastic fibres, a protein polysaccharide ground substance, and connective tissue cells (fibroblasts, macrophages, mast cells, and sometimes fat cells, plasma cells, leukocytes, and pigment cells). (05 Mar 2000) |
| bone tissue | A connective tissue, the matrix of which consists of collagen fibres and ground substance and in which are deposited calcium salts (phosphate, carbonate, and some fluoride) in the form of an apatite. Synonym: bone tissue. (05 Mar 2000) |
| border tissue movements | The action of the muscles and other tissues adjacent to the borders of a denture. (05 Mar 2000) |
| brain tissue transplantation | Transference of brain tissue, either from a foetus or from a born individual, between individuals of the same species or between individuals of different species. (12 Dec 1998) |